Annual CFF
$16.38 M
-$17.91 M-52.24%
31 December 2023
Summary:
PDS Biotechnology annual cash flow from financing activities is currently $16.38 million, with the most recent change of -$17.91 million (-52.24%) on 31 December 2023. During the last 3 years, it has fallen by -$32.51 million (-66.50%). PDSB annual CFF is now -88.26% below its all-time high of $139.52 million, reached on 31 December 2015.PDSB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$17.20 K
+$31.00 K+224.64%
30 September 2024
Summary:
PDS Biotechnology quarterly cash flow from financing activities is currently $17.20 thousand, with the most recent change of +$31.00 thousand (+224.64%) on 30 September 2024. Over the past year, it has dropped by -$10.75 million (-99.84%). PDSB quarterly CFF is now -99.98% below its all-time high of $84.60 million, reached on 31 December 2015.PDSB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$30.78 M
-$785.10 K-2.49%
30 September 2024
Summary:
PDS Biotechnology TTM cash flow from financing activities is currently $30.78 million, with the most recent change of -$785.10 thousand (-2.49%) on 30 September 2024. Over the past year, it has increased by +$14.41 million (+87.96%). PDSB TTM CFF is now -77.94% below its all-time high of $139.52 million, reached on 31 December 2015.PDSB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PDSB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -99.8% | +88.0% |
| 3 y3 years | -66.5% | +100.0% | -37.0% |
| 5 y5 years | +2083.5% | +100.0% | +4004.2% |
PDSB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.5% | at low | -99.9% | +224.6% | -37.0% | >+9999.0% |
| 5 y | 5 years | -66.5% | +2083.5% | -100.0% | +224.6% | -53.8% | >+9999.0% |
| alltime | all time | -88.3% | +180.8% | -100.0% | +100.1% | -77.9% | +248.4% |
PDS Biotechnology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $17.20 K(-224.6%) | $30.78 M(-2.5%) |
| June 2024 | - | -$13.80 K(-100.1%) | $31.57 M(-0.8%) |
| Mar 2024 | - | $20.01 M(+85.9%) | $31.82 M(+94.3%) |
| Dec 2023 | $16.38 M(-52.2%) | $10.77 M(+1241.9%) | $16.38 M(+6.9%) |
| Sept 2023 | - | $802.30 K(+234.3%) | $15.32 M(-60.8%) |
| June 2023 | - | $240.00 K(-94.7%) | $39.07 M(+0.6%) |
| Mar 2023 | - | $4.57 M(-52.9%) | $38.85 M(+13.3%) |
| Dec 2022 | $34.29 M(-29.9%) | $9.71 M(-60.5%) | $34.29 M(+39.5%) |
| Sept 2022 | - | $24.55 M(>+9900.0%) | $24.58 M(>+9900.0%) |
| June 2022 | - | $22.40 K(+198.7%) | $153.40 K(-99.7%) |
| Mar 2022 | - | $7500.00(>+9900.0%) | $48.90 M(+0.0%) |
| Dec 2021 | $48.89 M(+63.9%) | $0.00(-100.0%) | $48.89 M(0.0%) |
| Sept 2021 | - | $123.50 K(-99.7%) | $48.89 M(-26.5%) |
| June 2021 | - | $48.77 M(>+9900.0%) | $66.55 M(+274.2%) |
| Mar 2021 | - | $0.00(0.0%) | $17.79 M(-40.4%) |
| Dec 2020 | $29.83 M(+3876.9%) | $0.00(-100.0%) | $29.83 M(0.0%) |
| Sept 2020 | - | $17.79 M(>+9900.0%) | $29.83 M(+147.7%) |
| June 2020 | - | $0.00(-100.0%) | $12.04 M(0.0%) |
| Mar 2020 | - | $12.04 M(>+9900.0%) | $12.04 M(+1505.4%) |
| Dec 2019 | $750.00 K | $0.00(0.0%) | $750.00 K(-103.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $0.00(0.0%) | -$20.74 M(+0.8%) |
| June 2019 | - | $0.00(-100.0%) | -$20.57 M(-0.0%) |
| Mar 2019 | - | $750.00 K(-103.5%) | -$20.57 M(+1.5%) |
| Dec 2018 | -$20.27 M(-189.9%) | -$21.49 M(<-9900.0%) | -$20.27 M(-1725.1%) |
| Sept 2018 | - | $169.80 K(-4951.4%) | $1.25 M(+10.9%) |
| June 2018 | - | -$3500.00(-100.3%) | $1.12 M(-95.2%) |
| Mar 2018 | - | $1.05 M(+3606.0%) | $23.55 M(+4.4%) |
| Dec 2017 | $22.55 M(+148.3%) | $28.40 K(-39.8%) | $22.55 M(+0.1%) |
| Sept 2017 | - | $47.20 K(-99.8%) | $22.53 M(-32.1%) |
| June 2017 | - | $22.42 M(>+9900.0%) | $33.19 M(+224.2%) |
| Mar 2017 | - | $54.70 K(+592.4%) | $10.24 M(+12.7%) |
| Dec 2016 | $9.08 M(-93.5%) | $7900.00(-99.9%) | $9.08 M(-90.3%) |
| Sept 2016 | - | $10.70 M(-2130.0%) | $93.67 M(+13.2%) |
| June 2016 | - | -$527.10 K(-51.9%) | $82.74 M(-38.9%) |
| Mar 2016 | - | -$1.10 M(-101.3%) | $135.50 M(-2.9%) |
| Dec 2015 | $139.52 M(+747.1%) | $84.60 M(<-9900.0%) | $139.52 M(+154.0%) |
| Sept 2015 | - | -$234.00 K(-100.4%) | $54.92 M(-0.4%) |
| June 2015 | - | $52.24 M(+1690.3%) | $55.15 M(+1790.3%) |
| Mar 2015 | - | $2.92 M | $2.92 M |
| Dec 2014 | $16.47 M(+3.6%) | - | - |
| Dec 2013 | $15.90 M | - | - |
FAQ
- What is PDS Biotechnology annual cash flow from financing activities?
- What is the all time high annual CFF for PDS Biotechnology?
- What is PDS Biotechnology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for PDS Biotechnology?
- What is PDS Biotechnology quarterly CFF year-on-year change?
- What is PDS Biotechnology TTM cash flow from financing activities?
- What is the all time high TTM CFF for PDS Biotechnology?
- What is PDS Biotechnology TTM CFF year-on-year change?
What is PDS Biotechnology annual cash flow from financing activities?
The current annual CFF of PDSB is $16.38 M
What is the all time high annual CFF for PDS Biotechnology?
PDS Biotechnology all-time high annual cash flow from financing activities is $139.52 M
What is PDS Biotechnology quarterly cash flow from financing activities?
The current quarterly CFF of PDSB is $17.20 K
What is the all time high quarterly CFF for PDS Biotechnology?
PDS Biotechnology all-time high quarterly cash flow from financing activities is $84.60 M
What is PDS Biotechnology quarterly CFF year-on-year change?
Over the past year, PDSB quarterly cash flow from financing activities has changed by -$10.75 M (-99.84%)
What is PDS Biotechnology TTM cash flow from financing activities?
The current TTM CFF of PDSB is $30.78 M
What is the all time high TTM CFF for PDS Biotechnology?
PDS Biotechnology all-time high TTM cash flow from financing activities is $139.52 M
What is PDS Biotechnology TTM CFF year-on-year change?
Over the past year, PDSB TTM cash flow from financing activities has changed by +$14.41 M (+87.96%)